Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-01

Clinical Trial Update: Evaluation of Efficacy and Safety of ATB-1011+ATB-1012 Co-administration for Essential Hypertension and Type II Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of co-administration of ATB-1011 with ATB-1012 for essential hypertension and type 2 diabetes; current status U…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATB-1011
  • ATB-1012

Snippet

Sponsor: Autotelicbio | Conditions: Essential Hypertension, Diabetes Mellitus, Type 2 | Phase 3 | Status: UNKNOWN